Trial
NCT05087628
PRV-3279-2a Trial in Systemic Lupus
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Provention Bio, a Sanofi Company
Collaborators
—
Condition
Systemic Lupus Erythematosus
Intervention
PRV-3279
Why stopped
Termination for Strategic Reasons
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-03